RAB27A and neoplasm: Both the deletion of Rab27a and the inhibition of nSMase2 (using GW4869) in the mouse model of drug-resistant breast cancer can effectively suppress tumor growth, surpassing the inhibitory impact of the anti-PD-L1 antibody at 30 and 60 units (41, 68).